FROM Ellen Matloff
Angelina Jolie, Breast Cancer and Radical Surgery In 1974, First Lady Betty Ford talked openly about her mastectomy, bringing the fears of every woman out into the open. Since then, much has changed, including the discovery of the BRCA 1 and 2 genes in 1994 and 95. This week, international super-star Angelina Jolie revealed her decision to have both breasts removed — even though she did not yet have cancer – starting a new conversation about what to do if genetic testing shows a high risk for the disease. Experts say the most important lesson is that even the testing is not for everyone, let alone a double mastectomy. There’s concern that many women will demand more treatment than they need, partly because of the "pink ribbon" culture and the medical industry. We hear more about the agonizing decisions women might be faced with all on their own.
Genetic Breakthroughs: Patents and Profits Mapping the human genome began "the biological gold rush of the 21st Century," with companies now owning patents on 4000 human genes. Today, the US Supreme Court is being asked to strike down two patents on BRCA 1 and BRCA 2, genes that helped doctors discover both breast and ovarian cancer. Nobody can do that without paying Myriad Genetics , which isolated the genes. But opponents argue the genes are "products of Nature." We hear about a case with long-term implications for the future of "personalized medicine" designed to serve the needs of each individual patient.
The President and America's infrastructure: Bait and switch? President Trump's $1 trillion infrastructure proposal may not be what it seems. We look at the prospects for much-needed improvements in roads, bridges and airports.
Is America turning its back on the world? President Trump has made no secret of his contempt for the United Nations — and he's not alone. But, will proposed cuts in US contributions be counterproductive to America's role in the world and to national security?
America's top diplomat faces challenges in Asia Whatever happened to America's "pivot to Asia?" That's just one of the questions left hanging since Rex Tillerson's first trip there as Secretary of State. Is the Trump Administration hoping to change Foreign Policy or maintain the status quo?